Newly Diagnosed With Prostate Cancer - How Aggressive Is Your Cancer


  • Estimate Your Risk

  • Very Low Risk

  • Low Risk

  • Intermediate Risk

  • High Risk

  • Very High Risk

  • Metastatic

Calculate


PSA:

Gleason Score:

Clinical Stage/Rectal Exam:

Note*:
Abnormal 1 : do not extend beyond prostate
Abnormal 2 : with extension beyond the prostate

Imaging:


Very Low Risk Prostate Cancer


  • PSA <10
  • Gleason 3+3=6 and less than 2cores
  • Clinical Exam: normal

Management Options


Clinical Trials


Resources


Low Risk of Prostate Cancer


  • PSA 0-10
  • Gleason 3+3=6 and more than 2cores
  • Clinical Exam: normal or 1/2 abnormality , one side only

Management Options


These men have a very low risk of dying from prostate cancer and generally do well with most forms of therapy. This is the most common form of prostate cancer.

Clinical Trials


Resources


Intermediate Risk Prostate Cancer


  • PSA 10-20
  • Gleason 3+4 or 4+3
  • Clinical Exam: Abnormality that does not extend beyond the boundary of the prostate

Management Options


Clinical Trials


Resources


High Risk Prostate Cancer


  • PSA >20
  • Gleason 4+4 or 4+5, more than 5 cores
  • Clinical Exam: Abnormality that extends beyound the prostate with no fixation

Management Options


These men have a much higher risk of recurrence with surgery or radiation or surveillance, and often benefit from more aggressive combination approaches.

Clinical Trials


Resources


Very High Risk Prostate Cancer

 

  • Gleason 5+4 or 4+5
  • Gleason 4+4 or 4+5 and more than 4 cores
  • Clinical Exam

Management Options


Clinical Trials


Resources


© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved. Disclaimer
Email: webmaster@urology.jhu.edu | 600 North Wolfe Street, Baltimore, Maryland 21287

urology second opinion urology second opinion